The roles of essential oils in the modulation of immune function: a pilot study

Completed

• Conditions: Immunomodulation in smokers/non-smokers; Haematological Disorders

• Registration Number: ISRCTN10793328
• Lead Sponsor: Fragrantia Investments (Australia)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-09-21
• Last Update Posted: 2015-01-13

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 20

Inclusion Criteria

Participants are to be:
1. Aged 18-60 years
2. Male
3. Willing to comply with study protocols
4. The smokers must consume 10 cigarettes per day, and have done so for at least a year
5. The non-smokers must have never smoked

Exclusion Criteria

Factors resulting in exclusion include:
1. any significant medical problem or chronic illness including the findings on assessment of:
a. Body mass index (BMI) >30 or <18
b. Undiagnosed hypertension
c. Pulse irregularities consistent with pathological cardiac dysrhythmia such as atrial fibrillation
2. History of allergies to fragrances
3. Current or recent dermatitis
4. Regular use of medications
5. Vitamin or supplement consumption
6. Alcohol intake of more than 7 standard drinks per week or greater than 4 on heaviest day
7. High levels of exercise (extreme strenuous exercise for over 60 min >twice per week)
8. Recreational drug use
9. Any acute illness or infection in the preceding 2 weeks

Study & Design

• Study Type: Interventional
• Study Design: Not specified